Evidence map›Paper›PMID 39101673›Full record

ArticleDevelopment (Cambridge, England)2024

Akt is a mediator of artery specification during zebrafish development.

Wenping Zhou, Joey J Ghersi, Emma Ristori, Nicole Semanchik, Andrew Prendergast, Rong Zhang, Paola Carneiro, Gabriel Baldissera, William C Sessa, Stefania Nicoli

Abstract read
In one paragraph

Article in Development (Cambridge, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Wenping ZhouVascular Biology & Therapeutics Program, Yale University School of Medicine, New Haven, CT 06520, USA.
Joey J GhersiVascular Biology & Therapeutics Program, Yale University School of Medicine, New Haven, CT 06520, USA.ORCID 0000-0002-3342-5940
Emma RistoriVascular Biology & Therapeutics Program, Yale University School of Medicine, New Haven, CT 06520, USA.
Nicole SemanchikVascular Biology & Therapeutics Program, Yale University School of Medicine, New Haven, CT 06520, USA.
Andrew PrendergastDepartment of Comparative Medicine, Yale zebrafish Research Core, Yale University School of Medicine, New Haven, CT 06510, USA.
Rong ZhangVascular Biology & Therapeutics Program, Yale University School of Medicine, New Haven, CT 06520, USA.
Paola CarneiroVascular Biology & Therapeutics Program, Yale University School of Medicine, New Haven, CT 06520, USA.
Gabriel BaldisseraYale Cardiovascular Research Center, Department of Internal Medicine, Section of Cardiology, Yale University School of Medicine, New Haven, CT 06511, USA.
William C SessaVascular Biology & Therapeutics Program, Yale University School of Medicine, New Haven, CT 06520, USA.
Stefania NicoliVascular Biology & Therapeutics Program, Yale University School of Medicine, New Haven, CT 06520, USA.ORCID 0000-0001-7055-340X

Funding

Surgery / Physiology CoreP01HL107205 · NHLBI · YALE UNIVERSITY · PI SIMONS, MICHAEL · 2012 to 2022
$18.8M
Insights into the Molecular and Cellular Mechanisms governing Endothelial FunctionR35HL139945 · NHLBI · YALE UNIVERSITY · PI SESSA, WILLIAM C · 2018 to 2021
$4.3M
miR-223 regulates endothelial to hematopoietic transitionR01DK118728 · NIDDK · YALE UNIVERSITY · PI HIRSCHI, KAREN KEMPER, NICOLI, STEFANIA · 2020 to 2023
$2.9M
Defining the cellular and molecular formation of the sympathetic neurovascular unitR01HL170949 · NHLBI · YALE UNIVERSITY · PI Stefania Nicoli · 2024 to 2026
$2.3M
PPIL4 modulation of Notch links neurovascular malformation to brain aneurismR01NS109160 · NINDS · YALE UNIVERSITY · PI NICOLI, STEFANIA · 2019 to 2023
$1.8M
American Heart AssociationFondation LeducqNHLBI NIH HHS P01 HL107205NHLBI NIH HHS R01 HL170949NHLBI NIH HHS R35 HL139945NIA NIH HHS P01 HL1070205NIDDK NIH HHS R01 DK118728NIH HHS R01DK118728-01NINDS NIH HHS R01 NS109160Yale University
6 · The paper itself

Abstract

The dorsal aorta (DA) is the first major blood vessel to develop in the embryonic cardiovascular system. Its formation is governed by a coordinated process involving the migration, specification, and arrangement of angioblasts into arterial and venous lineages, a process conserved across species. Although vascular endothelial growth factor a (VEGF-A) is known to drive DA specification and formation, the kinases involved in this process remain ambiguous. Thus, we investigated the role of protein kinase B (Akt) in zebrafish by generating a quadruple mutant (aktΔ/Δ), in which expression and activity of all Akt genes - akt1, -2, -3a and -3b - are strongly decreased. Live imaging of developing aktΔ/Δ DA uncovers early arteriovenous malformations. Single-cell RNA-sequencing analysis of aktΔ/Δ endothelial cells corroborates the impairment of arterial, yet not venous, cell specification. Notably, endothelial specific expression of ligand-independent activation of Notch or constitutively active Akt1 were sufficient to re-establish normal arterial specification in aktΔ/Δ. The Akt loss-of-function mutant unveils that Akt kinase can act upstream of Notch in arterial endothelial cells, and is involved in proper embryonic artery specification. This sheds light on cardiovascular development, revealing a mechanism behind congenital malformations.

Indexed as

ArteriesProto-Oncogene Proteins c-aktReceptors, NotchZebrafishZebrafish ProteinsAnimalsEmbryo, NonmammalianEndothelial CellsGene Expression Regulation, DevelopmentalMutationSignal TransductionVascular Endothelial Growth Factor AProto-Oncogene Proteins c-aktReceptors, NotchVascular Endothelial Growth Factor AZebrafish ProteinsAkt and Notch signalingArtery specificationEndothelial cellsSingle cell RNA sequencingVascular developmentZebrafish embryo

Identifiers

PMID39101673
PMCPMC11441982

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.